Cargando…
Optimizing sodium-glucose co-transporter 2 inhibitor use in patients with heart failure with reduced ejection fraction: A collaborative clinical practice statement
Heart failure with reduced ejection fraction (HFrEF) is a debilitating disease that is associated with substantial morbidity, mortality, and societal costs. The past three decades have brought about significant advancements in the pharmacologic management of HFrEF, and a corresponding reduction in m...
Autores principales: | Warden, Bruce A., Steiner, Johannes, Camacho, Albert, Nguyen, Khoa, Purnell, Jonathan Q, Barton Duell, P., Craigan, Courtney, Osborn, Diane, Fazio, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315663/ https://www.ncbi.nlm.nih.gov/pubmed/34327503 http://dx.doi.org/10.1016/j.ajpc.2021.100183 |
Ejemplares similares
-
Real-world utilization of pharmacotherapy with new evidence-based cardiovascular indications in an academic preventive cardiology practice
por: Warden, Bruce A., et al.
Publicado: (2021) -
Consensus statement for implantation and follow-up of cardiac implantable electronic devices in India
por: Bohora, Shomu, et al.
Publicado: (2018) -
Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
por: Lim, Myong Cheol, et al.
Publicado: (2017) -
2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients()()
por: Shah, Maully J., et al.
Publicado: (2021) -
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
por: Lee, Shin-Wha, et al.
Publicado: (2017)